J01DH51 - Imipenem and Cilastatin |
Probably not porphyrinogenic |
PNP |
Rationale
Insignificant hepatic metabolism, no data pointing to CYP interaction; both components are mainly excreted in unchanged form in urine. To be observed: Tienam medication gives a mauve colour to the urine sample in the colorimetric PBG-assay, causing a false positive reaction.
Chemical description
Imipenem is a parenterally administered bata-lactam antibiotic of tienamycin type used in intraabdominal and acute gynaecological infections and pneumonia. Cilastatin is an enzyme inhibitor which inhibits the metabolism of imipenem in the kidneys. About 70-80% of the imipenem as well as of cilastatin is excreted in urine in unchanged form. The rest of impenem is metabolized in the kidneys by splitting of the beta-lactam ring. Around 10% of the cilastatin is excreted as the metabolite N-acetylcilastatin.
Personal communication
Andersson: Occasionally used without side effects.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames